ArticleF1000prime reports2013
Early diagnosis of lung cancer.
Article in F1000prime reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Trial
- Self-blaming as a barrier to lung cancer screening and smoking cessation programs in Italy. A qualitative study.PloS one · 2025Article
- Artificial intelligence: revolutionizing robotic surgery: review.Annals of medicine and surgery (2012) · 2024Review
- Computer-Assisted Image Processing System for Early Assessment of Lung Nodule Malignancy.Cancers · 2022Article
- A novel technology to integrate imaging and clinical markers for non-invasive diagnosis of lung cancer.Scientific reports · 2021Article
- 2D CNN versus 3D CNN for false-positive reduction in lung cancer screening.Journal of medical imaging (Bellingham, Wash.) · 2020Article
- Discriminating lung adenocarcinoma from lung squamous cell carcinoma using respiration-induced tumor shape changes.Physics in medicine and biology · 2018Article
- Contribution of nonattenuation-corrected images on FDG-PET/CT in the assessment of solitary pulmonary nodules.La Radiologia medica · 2016Article
- Serum anti-MDM2 and anti-c-Myc autoantibodies as biomarkers in the early detection of lung cancer.Oncoimmunology · 2016Article
- Approach to a solid solitary pulmonary nodule in two different settings-"Common is common, rare is rare".Journal of thoracic disease · 2014Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A large randomized controlled trial, The National Lung Screening Study (NLST), has demonstrated that screening with low-dose spiral computed tomography saved lives from lung cancer when compared with screening with chest radiographs. This is the first test showing efficacy in screening for lung cancer as previous trials of chest radiographs and sputum cytology failed to result in fewer deaths with screening. This review will examine the problem of lung cancer, the issues presented by screening, and the results of computed tomography (CT) studies for lung cancer screening. Now that CT screening has been shown to be effective, implementation of screening becomes the next step.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.